Company: MDCXW
Filing Date: 2025-06-30
Form Type: 253G2
Source: 0001062993-25-012235
Chunk: 3

Company: Medicus Pharma Ltd.
Filing Date: 2025-06-30
Form: 253G2
Chunk 3
---
 to, among other things, entry into the Definitive Agreement, as described in Item 1.01 above. Item 9.01. Financial Statements and Exhibits. (d) Exhibits.

| Exhibit No. 
 2.1*        |   | Description                                                                                                                                                      
 Share Exchange Agreement, dated June 29, 2025, by and between Medicus Pharma Ltd., Antev Limited and each of the securityholders of Antev Limited party thereto. |
|:------------|:--|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 104.1       | ​ | Cover Page Interactive Data File (embedded within the inline XBRL document).                                                                                     |

| * |     | To be filed by amendment. |

Forward Looking Statements Certain information in this Current Report on Form 8-K constitutes "forward-looking information" under applicable securities laws. "Forward-looking information" is defined as disclosure regarding possible events, conditions or financial performance that is based on assumptions about future economic conditions and courses of action and includes, without limitation, statements regarding the proposed Antev transaction and associated terms and timing thereof, the potential benefits of the Antev transaction, if consummated, including plans and expectations concerning, and future outcomes relating to, the development, advancement and commercialization of Teverelix, and the potential market opportunities related thereto. Forward-looking statements are often but not always, identified by the use of such terms as "may", "on track", "aim", "might", "will", "will likely result", "would", "should", "estimate", "plan", "project", "forecast", "intend", "expect", "anticipate", "believe", "seek", "continue", "target" or the negative and/or inverse of such terms or other similar expressions. These statements involve known and unknown risks, uncertainties and other factors, which may cause actual results, performance or achievements to differ materially from those expressed or implied by such statements, including those risk factors described in the Company's annual report on form 10-K for the year ended December 31, 2024 (the "Annual Report"), and in the Company's other public filings on EDGAR and SEDAR+, which may impact, among other things, the trading price and liquidity of the Company's common shares. Forward-looking statements contained in this Current Report on Form 8-K are expressly qualified by this cautionary statement and reflect our expectations as of the date hereof and thus are subject to change thereafter. The Company disclaims